Johnson & Johnson and DePuy Orthopaedics settled ongoing litigation surrounding allegations the company used deceptive marketing claims for two metal-on-metal implants for $120 million, according to Reuters.
The Latest
The 1,000th patient completed one-year of follow-up in X-Bolt Orthopaedics' World Hip Trauma Evaluation 4 study.
Emily R. Dodwell, MD, is an orthopedic surgeon at the Hospital for Special Surgery in New York City.
The Nottingham (U.K.) Trent University's medical design research group is developing robotic arms to assist in spine surgery, according to Zenopa.
Here are eight key notes from orthopedic and spine device companies in the past week.
Spine surgeon Andrew Parkinson, MD, is moving his practice in Oklahoma City seven miles north to across from the Oklahoma Spine Hospital in Oklahoma City.
Frank H. Valone III, MD, is an orthopedic spine surgeon at California Pacific Orthopaedics in San Francisco.
Johnson & Johnson reported orthopedics sales decreased 1 percent in the fourth quarter of 2018 to $2.2 billion; for the full year, orthopedic sales dipped 1.9 percent to $8.8 billion.
European private equity firm Nordic Capital acquired majority holding in Orchid Orthopedic Solutions from Altor Fund III.
Johnson & Johnson reported fourth quarter and full-year results for DePuy Synthes, its orthopedics division.